{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-26-000031","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2026-06-17T10:05:23+00:00","discovered_at":"2026-06-17T10:10:00.286886+00:00","generated_at":"2026-06-17T10:10:08.291905+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeoGenomics prices $275M convertible notes due 2032; to repurchase $276M of existing notes","bullets":["$275M principal of 0.75% convertible notes due 2032; initial purchasers have option for additional $41.25M.","Initial conversion price ~$14.16/share, a 35% premium to $10.49 closing price on June 16, 2026.","Net proceeds ~$266.15M; ~$25M used for capped call transactions (cap price $20.98/share).","Concurrently repurchasing $276M of existing 0.25% convertible notes due 2028 for ~$263.19M.","Also plans to repurchase up to $25M of common stock from certain note purchasers; offering expected to close June 22, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-26-000031","json":"https://secwatch.observer/filing/0001077183-26-000031.json","markdown":"https://secwatch.observer/filing/0001077183-26-000031.md","text":"https://secwatch.observer/filing/0001077183-26-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718326000031/0001077183-26-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718326000031/neo-20260617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T10:10:08.291905+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}